At Reon Biotech, we pioneer advanced solutions to combat antimicrobial resistance through
cutting-edge research, innovative formulations, and patient-centric approaches.
We believe in thinking outside the box when it comes to dosing strategies. Our alternative dosing solutions are designed to optimize treatment outcomes while minimizing side effects and resistance development.
Tailored dosing strategies that maximize efficacy while reducing adverse effects and preventing resistance development.
Advanced pharmacokinetic/pharmacodynamic modeling to establish optimal dosing schedules for various patient populations.
Customized dosing protocols based on individual patient characteristics, comorbidities, and treatment responses.
Rigorous clinical trials and real-world evidence studies to validate the safety and efficacy of alternative dosing regimens.
Our team of experts works tirelessly to develop unique dosage formulations that enhance the effectiveness and patient compliance of antibiotic and antifungal treatments.
Formulations designed for sustained drug release, reducing dosing frequency and improving patient adherence.
Pediatric and geriatric-friendly formulations with improved palatability and ease of administration.
Stable and ready-to-use injectable formulations for hospital and clinical settings.
Fixed-dose combinations that simplify treatment regimens and enhance therapeutic outcomes.
Our innovative Beta-lactamase Inhibitors are at the forefront of the battle against bacterial resistance, designed to counteract resistance mechanisms and enhance antibiotic efficacy.
Effective against a wide range of beta-lactamase enzymes, including ESBLs and carbapenemases.
Optimized combinations with beta-lactam antibiotics for enhanced antimicrobial activity.
Ready-to-use formulations specifically designed for critical care and hospital settings.
Enhanced stability profiles for improved shelf-life and storage conditions.
Comprehensive R&D services from discovery through development, leveraging cutting-edge technologies and scientific expertise.
High-throughput screening and rational drug design for novel antimicrobial agents.
Comprehensive in vitro and in vivo studies to establish safety and efficacy profiles.
Development of stable, bioavailable, and patient-friendly dosage forms.
Complete regulatory strategy and documentation support for global submissions.
Collaborative opportunities for pharmaceutical companies, research institutions, and healthcare organizations.
GMP-compliant manufacturing facilities for scale-up and commercial production.
Partnerships with ing research institutions for innovative discovery projects.
Licensing opportunities for our innovative formulations in global markets.
Strategic joint ventures for co-development and commercialization of products.
We provide end-to-end pharmaceutical services, from research and development to manufacturing and commercialization.
Innovative dosing strategies optimized for efficacy, safety, and resistance prevention through advanced PK/PD modeling.
Contact UsDevelopment of unique dosage forms including extended-release, pediatric-friendly, and combination formulations.
Contact UsCutting-edge Beta-lactamase Inhibitors designed to combat antibiotic resistance and enhance therapeutic outcomes.
Contact UsComprehensive in vitro and in vivo studies to establish safety, efficacy, and pharmacokinetic profiles.
Contact UsGMP-compliant manufacturing with scale-up capabilities for clinical and commercial production.
Contact UsExpert guidance on regulatory submissions, compliance, and approvals for global markets.
Contact UsA systematic approach to pharmaceutical innovation that ensures quality, efficacy, and patient safety at every stage.
Identify novel targets and develop innovative approaches to combat antimicrobial resistance.
Formulation optimization, preclinical studies, and analytical method development.
Clinical trials, stability studies, and manufacturing process validation.
Regulatory submissions, scale-up manufacturing, and market launch support.
Partner with Reon Biotech for innovative pharmaceutical solutions that address the growing challenge of antimicrobial resistance.
